Literature DB >> 4747579

The primary immune response to haemocyanin in patients with primary biliary cirrhosis.

R A Fox, F J Dudley, S Sherlock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4747579      PMCID: PMC1553816     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  18 in total

1.  The human primary immune response to keyhole limpet haemocyanin: interrelationships of delayed hypersensitivity, antibody response and in vitro blast transformation.

Authors:  J E Curtis; E M Hersh; J E Harris; C McBride; E J Freireich
Journal:  Clin Exp Immunol       Date:  1970-04       Impact factor: 4.330

2.  Immunosuppressive therapy. The relation between clinical response and immunologic competence.

Authors:  M A Swanson; R S Schwartz
Journal:  N Engl J Med       Date:  1967-07-27       Impact factor: 91.245

3.  Cell-mediated immunity in patients with leprosy.

Authors:  J L Turk; M F Waters
Journal:  Lancet       Date:  1969-08-02       Impact factor: 79.321

Review 4.  A unified concept of autoimmune hepatitis.

Authors:  D Doniach; J G Walker
Journal:  Lancet       Date:  1969-04-19       Impact factor: 79.321

5.  Impaired delayed hypersensitivity in primary biliary cirrhosis.

Authors:  S Sherlock; R A Fox; D G James; P J Scheuer; O Sharma
Journal:  Lancet       Date:  1969-05-10       Impact factor: 79.321

6.  Immune response to hemocyanin in normal, thymus-deprived and reconstituted mice.

Authors:  J Krüger; R K Gershon
Journal:  J Immunol       Date:  1971-04       Impact factor: 5.422

7.  Inhibition of PHA-stimulated lymphocyte transformation by plasma from patients with advanced alcoholic cirrhosis.

Authors:  C C Hsu; C M Leevy
Journal:  Clin Exp Immunol       Date:  1971-05       Impact factor: 4.330

8.  Tetanus antitoxin production and gamma globulin levels in patients with cirrhosis of the liver.

Authors:  M Bjorneboe; K B Jensen; I Scheibel; A C Thomsen; M W Bentzon
Journal:  Acta Med Scand       Date:  1970-12

9.  Primary biliary cirrhosis.

Authors:  P Scheuer
Journal:  Proc R Soc Med       Date:  1967-12

10.  Development of macrophages in phytohaemagglutinin cultures of blood from patients with idiopathic steatorrhoea and with cirrhosis.

Authors:  G C Winter; C F McCarthy; A E Read; J M Yoffey
Journal:  Br J Exp Pathol       Date:  1967-02
View more
  8 in total

Review 1.  Pathogenic mechanisms in primary biliary cirrhosis.

Authors:  H C Thomas; O Epstein
Journal:  Springer Semin Immunopathol       Date:  1980-12

2.  Hepatocyte damage induced by lymphocytes from patients with chronic liver diseases, as detected by LDH release.

Authors:  E Fernandez-Cruz; P Escartin; A Bootello; M Kreisler; J M Segovia de Arana
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

3.  Basophils in tuberculin and "Jones-Mote" delayed reactions of humans.

Authors:  P W Askenase; J E Atwood
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

4.  Injurious effect on rat liver mitochondria by lymphocytes from patients with primary biliary cirrhosis.

Authors:  A Bootello; E Fernandez-Cruz; P Escartin; M F Blanco; M Gosalvez; J M Segovia De Arana
Journal:  Clin Exp Immunol       Date:  1976-05       Impact factor: 4.330

5.  Antiviral cell-mediated immune responses and effect of chromosome polymorphism in Herpesvirus saimiri-infected monkeys.

Authors:  R H Neubauer; H Rabin; F E Dunn
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

6.  Circulating activated B cells in primary biliary cirrhosis.

Authors:  S P James; E A Jones; J H Hoofnagle; W Strober
Journal:  J Clin Immunol       Date:  1985-07       Impact factor: 8.317

7.  Alterations of T-cell subsets in primary biliary cirrhosis.

Authors:  A K Bhan; J L Dienstag; J R Wands; S F Schlossman; E L Reinherz
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

8.  Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response.

Authors:  R A Murgita; T B Tomasi
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.